LXRX — Lexicon Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $662.98m
- $523.81m
- $49.80m
Lexicon Pharmaceuticals Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Lonnel Coats Retires As CEO And Board Member Of Lexicon Pharmaceuticals
Lexicon Pharmaceuticals Inc expected to post a loss of 20 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Blackline, Medpace Holdings, Roblox
Brief: Lexicon Pharmaceuticals Files For Resale Of Up To 57.7 Million Shares By The Selling Stockholders - SEC Filing
U.S. STOCKS ON THE MOVE-Acelyrin, Endeavour Silver, B2Gold
U.S. STOCKS ON THE MOVE-Viatris, National Fuel Gas, Moderna
U.S. STOCKS ON THE MOVE-Hyatt, Fortrea, China ADRs
Lexicon rises on plan to resubmit marketing application for diabetes drug
Brief: Lexicon Announces Oversubscribed $250 Million Private Placement Of Equity Securities
Brief: Lexicon Preparing To Resubmit Sotagliflozin NDA For Type 1 Diabetes Following Feedback From FDA
Lexicon Pharmaceuticals Inc expected to post a loss of 22 cents a share - Earnings Preview
Brief: Lexicon Pharmaceuticals Provides Business And Pipeline Update
Brief: Lexicon Pharmaceuticals- Entered Into Open Market Sale Deal
Brief: Lexicon Enrolls First Patient In Phase 2B Progress Study Of Lx9211 In Diabetic Peripheral Neuropathic Pain (Dpnp)
Lexicon Pharmaceuticals Inc expected to post a loss of 21 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Hyatt Hotels, Walmart, Maxeon
U.S. STOCKS ON THE MOVE-Olema Pharma, Akamai Technologies, US banks
U.S. STOCKS ON THE MOVE-PepsiCo, Electronic Arts, Honeywell